Independent association of high serum uric acid concentration with angiographically defined coronary artery disease

Tohoku Journal of Experimental Medicine

Volumn 211, Issue 4, 2007, Pages 369-377

  Jelić Ivanović, Zorana ^a   Memon, Lidija ^b   Spasojević Kalimanovska, Vesna ^a   Bogavac Stanojević, Nataša ^a   Spacić, Slavica ^a  

^a Department of Physical Chemistry   (Yugoslavia)

^b Clinical Center Bezanijska Kosa   (Yugoslavia)

Author keywords

Angiography; Atherosclerosis; Coronary heart disease; Risk factors; Uric acid

Indexed keywords

C REACTIVE PROTEIN; DIURETIC AGENT; URIC ACID;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENDER BIAS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; URIC ACID BLOOD LEVEL; WAIST HIP RATIO;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; URIC ACID;

EID: 34247159137     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.211.369     Document Type: Article

References (27)

1. Aboa Eboule, A.C., De Smet, P., Dramaix, M., De Backer, G. & Kornitzer, M. (2001) Relation between uricemia and all-causes cardiovascular and coronary mortality in both genders of non-selected sample of the Belgium population. Revue d' Epidemiologie et de Sant ́Publique, 17, 1097-1104.
2. Alderman, M.H. (2002) Uric acid and cardiovascular risk. Curr. Opin. Pharmacol. 2, 126-130.
3. Alderman, M. & Redfern, J.S. (2004) Serum uric acid - a cardiovascular risk factor? Ther. Umsch., 61, 547-552.
4. Baker, J.F., Krishnan, E., Chen, L. & Schumacher, H.R. (2005) Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? Am. J. Med., 118, 816-826.
5. 1, lipoprotein(a) and cellular adhesion molecules in angiographically assessed coronary artery disease. Clin. Chem. Lab. Med., 41, 893-898.
6. Bogavac-Stanojevic, N., Jelic-Ivanovic, Z., Djurovic, S., Spasojevic-Kalimanovska, V., Spasic, S., Kalimanovska-Ostric, D. & Memon, L. (2005) Lack of association between low HDL-cholesterol and elevated circulating adhesion molecules in normolipidemic CAD patients and healthy controls. Int. Heart J., 46, 593-600.
7. Culleton, B.F., Larson, M.G., Kannel, W.B. & Levy, D. (1999) Serum uric acid and risk of cardiovascular disease and mortality: the Framingham Heart Study. Ann. Intern. Med., 31, 7-13.
8. Fang, J. & Alderman, M.H. (2000) Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow up study. JAMA, 283, 2404-2410.
9. Friedewald, W.T., Levy, R.I. & Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18, 499-502.
10. Gertler, M.M., Garn, S.M. & Levine, S.A. (1951) Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann. Intern. Med., 34, 1421-1431.
11. Hayden, M.R. & Tyagi S.C. (2004) Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr. Metab. (Lond.), 1, 10.
12. Hiyamuta, K., Toshima, H., Koga, Y., Nakayama, H., Yamaga, A., Shiraishi, A., Maruyama, H., Hidaka, Y, Ueno, T. & Yoshiga, O. (1990) Relationship between coronary risk factor and arteriographic feature of coronary atherosclerosis. Jpn. Circ. J., 34, 442-447.
13. Hoieggen, A., Alderman, M.H., Kjeldsen, S.E., Julius, S., Devereus, R.B., De Faire, U., Fyhrquist, F., Ibsen, H., Kristianson, K., Lederballe-Pedersen, O., Lindholm, L.H., Nieminen, M.S., Omvik, P., Oparil, S., Wedel, H., Chen, C., Dahlof, B. & LIFE Study Group (2004) The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int., 65, 1041-1049.
14. Johnson, R.J. & Tuttle, K.R. (2000) Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease. Hypertension, 35, E10.
15. Johnson, R.J., Kang, D-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K.R., Rodriguez-Iturbe, B., Herrera-Acosta, J. & Mazzali, M. (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension, 41, 1183-1190.
16. Kotake, H., Sawada, Y., Hoshio, A., Shirota, K., Tomokuni, A., Doi, T., Hisatome, I. & Mashiba, H. (1992) Relation between serum uric acid and angiographically defined coronary artery disease in postmenopausal women. J. Med., 23, 409-415.
17. Madsen, T.E., Muhlestein, J.B., Carlquist, J.F., Home, B.D., Bair, T.L., Jackson, J.D., Lappe, J.M., Pearson, R.R. & Anderson, J.L. (2005) Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease. Am. J. Nephrol., 25, 45-49,
18. Memon, L., Spasojević-Kalimanovska, V., Bogavac-Stanojević, N., Kalimanovska-Oštrić, D., Jelić-Ivanović, Z., Spasić, S. & Topić, A. (2006) Association of C-reactive protein and fibrinogen with the presence and extent of angiographically verified coronary artery disease. Tohoku J. Exp. Med., 209, 197-206.
19. Mercuro, G., Vitale, C., Cerquetani, E., Zoncu, S., Deidda, M., Fini, M. & Rosano, G.M. (2004) Effect of hyperuricaemia upon endothelial function in patients at increased cardiovascular risk. Am. J. Cardiol.. 94, 932-935.
20. Moriarity, J.T., Folsom, A.R., Iribarren, C., Nieto, F.J. & Rosamond, W.D. (2000) Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann. Epidemiol., 10, 136-143.
21. Niskanen, L.K., Laaksonen, D.E., Nyyssönen, K., Alfthan, G., Lakka, H.M., Lakka T.A. & Salonen, J.T. (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch. Intern. Med., 164, 1546-1551.
22. Rich, M.W. (2000) Uric acid: Is it a risk factor for cardiovascular disease? Am. J. Cardiol., 85, 1018-1021.
23. Simon, J.A., Lin, F., Vittinghoff, E. & Bittner, V., for the Heart and Estrogen-Progestin Replacement Study (HERS) Research Group (2006) The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: The Heart and Estrogen-Progestin Replacement Study (HERS). Ann. Epidemiol., 16, 138-145.
24. Tuttle, K., Short, R. & Johnson, R. (2001) Sex differences in uric acid and risk factors for coronary artery disease. Am. J. Cardiol., 87, 1411-1414.
25. Vukomirovic, D. (2005) Causes of deaths. In: Statistical Yearbook of Serbia 2005, Statistical Office of the Republic of Serbia, Belgrade, Serbia, p. 90.
26. World Health Organization (2002) Part one - The health situation in the European region. In: The European Health Report, pp. 11-14.
27. Yang, Q., Guo, C-Y., Cupples, L.A., Levy, D., Wilson, P.W.F. & Fox, C.S. (2005) Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabol. Clin. Exp., 54, 1435-1441.